M. Isaka et al.
derivative 32 was synthesized from 2 and 2-chloro-5-
nitropyridine.
discussions and valuable suggestions on antibacterial activities of
Aspergillus depsidones.
The semisynthetic nidulin derivatives were tested for
activities against Gram-positive bacteria, B. cereus ATCC
Compliance with ethical standards
1
1778, E. faecium ATCC 51559, and Staphylococcus aur-
Conflict of interest The authors declare that they have no conflict of
interest.
eus ATCC 29213 [8], and cytotoxicity to nonmalignant
Vero cells (African green monkey kidney fibroblasts) [9]
(
Table 1). Most of the 8-O-alkyl derivatives with short side-
References
chain showed more potent antibacterial activity than nidu-
lin. Among these derivatives, compound 5 (8-O-butyl)
exhibited highest activity against B. cereus (MIC 0.391 μg
1
. Motti CA, Bourne DG, Burnell JN, Doyle JR, Haines DS, Liptrot
CH, Llewellyn LE, Ludke S, Muirhead A, Tapiolas DM.
Screening marine fungi for inhibitors of the C4 plant enzyme
pyruvate phosphate dikinase: unguinol as a potential novel her-
bicide candidate. Appl Environ Microbiol. 2007;73:1921–7.
. Feighner SD, Salituro GM, Smith JL, Tsou NN Unguinol and
analogs are animal growth permittants. US Patent, US 5350763;
−
1
ml ). Alkyl derivatives with long side chain, 8 and 9,
showed much weaker antibacterial activity. It should also be
noted that certain level of steric bulkiness of the alkyl group
may be accepted (15, 16, and 22). On the other hand, weak
antibacterial activities of compounds 19–21, and 23 sug-
gested that polar functional group on the alkyl side-chain
significantly reduces the activity. Acylated derivatives (24
and 25) exhibited weaker activity. All of the O-aryl deri-
vatives (26–32) showed potent antibacterial activity.
2
3
1
994.
. Sureram S, Kesornpun C, Mahidol C, Ruchirawat S, Kittakoop P.
Directed biosynthesis through biohalogenation of secondary
metabolites of marine-derived fungus Aspergillus unguis. RSC
Adv. 2013;3:1781–8.
4
. Sureram S, Wiyakrutta S, Ngamrojanavanich N, Mahidol C,
Ruchirawat S, Kittakoop P. Depsidones, aromatase inhibitors and
radical scavenging agents from the marine-derived fungus
Aspergillus unguis CRI282-03. Planta Med. 2012;78:582–8.
To further demonstrate the antibacterial potential, nidulin
1, lead compound) and five high-activity derivatives were
(
selected and tested for activity against Methicillin-resistant
S. aureus SK1 (MRSA) [10] by one of the authors (S.P.). In
particular, compounds 26, 30, and 31, were significantly
5. Klaiklay S, Rukachaisirikul V, Aungphao W, Phongpaichit S,
Sakayaroj J. Depsidone and phthalide derivatives from the soil-
derived fungus Aspergillus unguis PSU-RSPG199. Tetrahedron
Lett. 2016;57:4348–51.
−
1
active also against MRSA (MIC 0.5 μg ml ).
6
. Phainuphong P, Rukachaisirikul V, Phongpaichit S, Sakayaroj J,
Kanjanasirirat P, Borwornpinyo S, Akrimajirachoote N, Yimnual C,
Muanprasat C. Depsides and depsidones from the soil-derived fungus
Aspergillus unguis PSU-RSPG204. Tetrahedron. 2018;74:5691–9.
. Morshed MT, Vuong D, Crombie A, Lacey AE, Karuso P, Lacey
E, Piggott AM. Expanding antibiotic chemical space around
nidulin pharmacophore. Org Biomol Chem. 2018;16:3038–51.
. Clinical and Laboratory Standards Institute (CLSI). Method for
dilution antimicrobial susceptibility test for bacteria that grow
aerobically. Approved Standard, M7-A7. Wayne: Clinical and
Laboratory Standards Institute; 2006.
Many of the synthetic compounds displayed weak to
moderate cytotoxicity to Vero cells. Since the SAR pattern
for cytotoxicity was different from that for antibacterial
activities, they could potentially be distinguishable through
synthetic design.
In conclusion, the present results demonstrate a possi-
bility of the Aspergillus depsidone (nidulin) as a core
structure for antibacterial agents. In particular, 8-O-aryl
ether derivatives have been shown to exhibit significant
activities against Gram-positive bacteria, including MRSA.
7
8
9. Hunt L, Jordan M, De Jesus M, Wurm FM. GFP-expressing
mammalian cells for fast, sensitive, noninvasive cell growth
assessment in a kinetic mode. Biotechnol Bioeng. 1999;65:201–5.
0. Clinical and Laboratory Standards Institute (CLSI). Methods for
dilution antimicrobial susceptibility tests for bacteria that grow
aerobically; approved standard CLSI document M07-A9. Wayne:
Clinical and Laboratory Standards Institute; 2012.
1
Acknowledgements Financial support from the Thailand Research
Fund (grant No. DBG5980002) is gratefully acknowledged. We thank
Professor Vatcharin Rukachaisirikul, Prince of Songkla University, for